Oxidative stress, inflammation and recovery of muscle function after damaging exercise: Effect of 6-weeks mixed antioxidant supplementation by Bailey, D M et al.
        
Citation for published version:
Bailey, DM, Williams, C, Betts, J, Thompson, D & Hurst, T 2011, 'Oxidative stress, inflammation and recovery of
muscle function after
damaging exercise: Effect of 6-weeks mixed antioxidant supplementation', European Journal of Applied
Physiology, vol. 111, no. 6, pp. 925-936. https://doi.org/10.1007/s00421-010-1718-x
DOI:
10.1007/s00421-010-1718-x
Publication date:
2011
Document Version
Peer reviewed version
Link to publication
The original publication is available at www.springerlink.com
University of Bath
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 13. May. 2019
In-Press October 2010 European Journal of Appied Physiology 
Title: Oxidative Stress, Inflammation and Recovery of 
Muscle Function after Damaging Exercise: Effect of 
6-weeks Mixed Antioxidant Supplementation. 
 
 
 
Authors: David M. Bailey
1 
 
Clyde Williams
1 
 James A. Betts
2 
Dylan Thompson
2 
Tina L. Hurst
3 
 
Affiliation:  
1 
School of Sport, Exercise & Health Sciences, Loughborough University, UK  
 
2
 Human Physiology Research Group, University of Bath, UK 
3 
Unilever Discovery, Colworth Park, Sharnbrook, Bedfordshire, UK. 
 
Contact: Dr James A. Betts 
Tel:  +44 1225 383 448 
Fax: +44 1225 383 275 
Email: J.Betts@bath.ac.uk 
 
This work was supported by a research grant from Unilever R & D. 
 
 2 
ABSTRACT 1 
There is no consensus regarding the effects of mixed antioxidant vitamin C and/or vitamin E 2 
supplementation on oxidative stress responses to exercise and restoration of muscle function.  3 
Thirty-eight men were randomly assigned to receive either placebo group (n=18) or mixed 4 
antioxidant (primarily vitamin C & E) supplements (n=20) in a double-blind manner.  After 6-5 
weeks, participants performed 90 minutes of intermittent shuttle-running.  Peak isometric torque 6 
of the knee flexors/extensors and range of motion at this joint were determined before and after 7 
exercise, with recovery of these variables tracked for up to 168 h post-exercise.  Antioxidant 8 
supplementation elevated pre-exercise plasma vitamin C (938 μmol·l-1) and vitamin E (113 9 
μmol·l-1) concentrations relative to baseline (P<0.001) and the placebo group (P≤0.02).  Exercise 10 
reduced peak isometric torque (i.e. 9-19% relative to baseline; P≤0.001), which persisted for the 11 
first 48 hours of recovery with no difference between treatment groups.  In contrast, changes in 12 
the urine concentration of F2-isoprostanes responded differently to each treatment (P=0.04), with 13 
a tendency for higher concentrations after 48 h of recovery in the supplemented group (6.26.1 14 
ng·ml
-1
 versus 3.73.4 ng·ml-1).  Vitamin C & E supplementation also affected serum cortisol 15 
concentrations, with an attenuated increase from baseline to the peak values reached after 1 h of 16 
recovery compared with the placebo group (P=0.02) and serum interleukin-6 concentrations 17 
were higher after 1 h of recovery in the antioxidant group (11.33.4 pg∙ml-1) than the placebo 18 
group (6.23.8 pg∙ml-1; P=0.05).  Combined vitamin C & E supplementation did not reduce 19 
markers of oxidative stress or inflammation nor did it facilitate recovery of muscle function after 20 
exercise-induced muscle damage. 21 
 22 
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 3 
INTRODUCTION 24 
Exercise places a degree of mechanical and metabolic stress on the body, which jointly 25 
contribute to a commonly-experienced sub-clinical pathological response involving oxidative 26 
stress and subsequent inflammation (Pyne 1994).  On one hand, this response plays a key role in 27 
the repair and regeneration of tissue as part of a long-term adaptive process, such that any 28 
interventions designed to acutely attenuate these responses have impaired training adaptations in 29 
some (Gomez-Cabrera et al. 2008) but not all (Yfanti et al. 2010) studies.  However, when 30 
coupled with an awareness of the distinction between physiological responses to chronic physical 31 
training and pathophysiological responses to an acute excessive overload of exercise (Brigelius-32 
Flohe 2009), this view can be balanced against the more immediate implications of exercise-33 
induced muscle damage in terms of transient sensitisation of afferent nerve endings, 34 
compromised integrity of myofibrillar contractile proteins and reduced insulin action (Friden and 35 
Lieber 1992; Kirwan et al. 1992; Smith 1991).  The resultant pain and impairment of muscular 36 
function and muscle glycogen resynthesis (Costill et al. 1990) after initial tissue injury thus have 37 
relevance to, for example: a relatively sedentary individual at the outset of an exercise program; 38 
a habitual exerciser planning a single novel activity beyond their usual regimen; and/or an athlete 39 
returning to sport after injury.  These populations would benefit from interventions to alleviate 40 
such symptoms in the short-term (Howatson and van Someren 2008), either to facilitate 41 
adherence to an exercise program or to offset decrements in performance. 42 
 43 
 Antioxidant vitamins are prime examples of such interventions.  Our previous work 44 
provided evidence for a modest beneficial effect of 2-weeks vitamin C supplementation in 45 
relation to changes in muscle function/soreness and certain aspects of oxidative stress (i.e. lipid 46 
peroxidation) and inflammation (i.e. cytokine response) after intermittent exercise (Thompson et 47 
al. 2001).  This benefit of vitamin C alone is consistent with other studies that have observed 48 
improved recovery of maximum voluntary contraction (Jakeman and Maxwell 1993) and 49 
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evidence of reduced lipid peroxidation (Alessio et al. 1997) following exercise-induced muscle 50 
damage.  Interestingly, the latter of these studies also observed a benefit of 21-days 51 
supplementation with vitamin C even relative to vitamin E (Jakeman and Maxwell 1993).  This 52 
result is of relevance given that others have reported independent effects of vitamin E in terms of 53 
reducing post-exercise markers of lipid peroxidation (i.e. urinary exretion of thiobarbituric acid 54 
adducts; Meydani et al. 1993) and secretion of cytokines involved in the inflammatory process, 55 
such as interleukin-6 and -1β (Cannon et al. 1991).  In contrast, when the activity of plasma 56 
creatine kinase has been used as an indirect measure of exercise-induced muscle damage, 57 
vitamin E supplementation alone has not reduced the efflux of this enzyme into the circulation 58 
(Cannon et al. 1990; Warren et al. 1992). 59 
 60 
 In addition to the effects of ingesting single antioxidants, more recent studies have 61 
explored the potential benefits of mixed antioxidants that are popular commercial products and 62 
may offer better synergism between various interrelated antioxidant networks in vivo (Powers et 63 
al. 2010).  Most commonly, vitamin C (ascorbic acid) and vitamin E (α-tocopherol) have been 64 
co-ingested (Bloomer et al. 2007; Bloomer et al. 2006; Dawson et al. 2002; Fischer et al. 2004; 65 
Howatson et al. 2009; Mastaloudis et al. 2004; Mastaloudis et al. 2006; Petersen et al. 2001; 66 
Rokitzki et al. 1994), although others have examined combined vitamin C and E supplements 67 
that also include smaller quantities of vitamin A (α-/β-carotene) precursors (Kanter et al. 1993; 68 
Machefer et al. 2007; Schroder et al. 2000) or selenium (Goldfarb et al. 2005), among other 69 
ingredients (i.e. lutein, zinc and magnesium; Teixeira et al. 2009).  These supplements have been 70 
evaluated using different types of exercise and, while some studies have reported reduced 71 
evidence of oxidative stress associated with vitamin C & E supplementation (Bloomer et al. 72 
2006; Fischer et al. 2004; Goldfarb et al. 2005; Machefer et al. 2007; Mastaloudis et al. 2004; 73 
Schroder et al. 2000), others report no difference relative to placebo supplementation (Bloomer 74 
et al. 2007; Bloomer et al. 2006; Dawson et al. 2002; Kanter et al. 1993; Rokitzki et al. 1994; 75 
Teixeira et al. 2009).  There appears to be more consistent results in relation to inflammatory 76 
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responses; the majority of studies report no effect of vitamin C & E supplementation on systemic 77 
cytokine responses following exercise (Bloomer et al. 2007; Mastaloudis et al. 2004; Petersen et 78 
al. 2001; Teixeira et al. 2009), although others have shown reduced concentrations of 79 
interleukin-6 and interleukin-1ra (Fischer et al. 2004).  Interestingly, that study also elegantly 80 
illustrated that this effect on interleukin-6 was attributable primarily to a net reduction in release 81 
from previously exercised skeletal muscle (Fischer et al. 2004). 82 
 83 
Notwithstanding the equivocal evidence regarding the effects of vitamin C & E 84 
supplementation on oxidative stress and inflammation, direct histological examination of muscle 85 
tissue via electron microscopy has not revealed any less ultrastructural disruption after exercise 86 
when supplemented with these vitamins (Dawson et al. 2002).  This finding is entirely consistent 87 
with every study to have reported blood-borne biomarkers (e.g. creatine kinase, myoglobin and 88 
lactate dehydgrogenase) as proxy measures of muscle damage (Bloomer et al. 2007; Dawson et 89 
al. 2002; Machefer et al. 2007; Mastaloudis et al. 2006; Petersen et al. 2001; Rokitzki et al. 1994; 90 
Teixeira et al. 2009), none of which has reported significant protective effects of combined 91 
vitamin C & E supplementation.  From this perspective, it is noteworthy that such biomarkers do 92 
not correlate well either with the magnitude of tissue injury (Komulainen et al. 1995) or 93 
impairment of muscle function (Margaritis et al. 1999), the latter of which is believed to 94 
represent the most valid indirect predictor of the degree of muscle damage sustained (Clarkson 95 
and Hubal 2002).  Combined with the fact that recovery of muscle function after exercise is also 96 
of clear practical value, it is interesting that only two studies have monitored the response of this 97 
variable to combined vitamin C & E intervention over the days following exercise (Bloomer et 98 
al. 2007; Mastaloudis et al. 2006).  Of these, neither reported any benefit of specific vitamin C & 99 
E supplements in relation to either muscle-specific resistance exercise (Bloomer et al. 2007) or 100 
ultra-endurance exercise (Mastaloudis et al. 2006).  However, these exercise models may not 101 
reflect the muscle damage typically experienced across a range of muscle groups during more 102 
common activities such as basketball, soccer or tennis involving high metabolic demand in 103 
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combination with repeated eccentric or unaccustomed muscle actions (i.e. high-intensity 104 
intermittent shuttle-running; Thompson et al. 1999). 105 
 106 
In summary, the potential for combined vitamin C & E supplementation to impact upon 107 
oxidative stress, inflammation and systemic indices of muscle damage after exercise remains 108 
uncertain and very little information is available regarding the recovery of muscle function.  The 109 
aim of the present study was therefore to examine the influence of 6-weeks of mixed antioxidant 110 
(primarily vitamin C & E) supplementation on oxidative stress, inflammation and the functional 111 
recovery of skeletal muscles after prolonged intermittent shuttle-running.  Based upon reports 112 
that all these outcomes can be affected when vitamin C or E are supplemented individually 113 
(Alessio et al. 1997; Cannon et al. 1991; Jakeman and Maxwell 1993; Meydani et al. 1993; 114 
Thompson et al. 2001), it is hypothesised that mixed antioxidant vitamin C & E supplementation 115 
will attenuate these responses and that, given the inhibitory effect of these processes on 116 
excitation-contraction coupling (Brown et al. 1996), this may translate into improved recovery of 117 
muscle function. 118 
119 
 7 
MATERIALS AND METHODS 120 
Approach to the Research Question 121 
The primary purpose of this study was to examine whether vitamin C & E 122 
supplementation presents any benefit in terms of facilitating functional recovery following 123 
exercise-induced muscle damage.  Given the inherent inter-individual variance associated with 124 
many measures of exercise-induced muscle damage, an ideal approach is to adopt a repeated-125 
measures cross-over design when assessing the efficacy of nutritional interventions (Betts et al. 126 
2009) and one study has employed this approach in relation to combined vitamin C & E 127 
supplements (Dawson et al. 2002).  However, in view of the slow intracellular turnover of 128 
vitamin E in many tissues (i.e. adipose tissue, adrenal glands, liver and skeletal muscle fibres;  129 
Packer 1992), it was decided that an independent-measures 2-group design would be most 130 
appropriate for this study but with a larger sample size (n = 18 & 20) than has previously been 131 
used in thus type of study (typically n = 10) in order to account for individual differences. 132 
 133 
This relatively large cohort of participants were randomly assigned to receive either a 134 
placebo supplement or a mixed antioxidant (primarily vitamin C & E) supplement for a period of 135 
6 weeks prior to completing a high-intensity intermittent shuttle-running protocol.  The use of 136 
this protocol both increases ecological validity with specific reference to participation in team-137 
sports and also has the potential to induce substantial muscle damage on a whole-body level 138 
through the combination of eccentrically-biased muscle actions (e.g. decelerations from repeated 139 
sprints and frequent changes of direction) and high metabolic demand (Thompson et al. 1999).  140 
Furthermore, as has recently been advocated (Powers et al. 2010), the antioxidant mixture 141 
provided in this study was a cocktail including not only vitamins C and E but also lesser 142 
quantities of other nutrients (detailed under „Supplementation‟) that act synergistically with more 143 
potent or direct antioxidants to protect against oxidative damage.  Obviously, should any 144 
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differences between treatments occur, a subsequent investigation would be required to isolate the 145 
mechanisms through which specific antioxidants operate. 146 
 147 
We employed multiple outcome measures to provide a more valid overall interpretation 148 
than would be possible using any one in isolation.  In particular, serial assessments of muscle 149 
function for up to a week following exercise represents a central novel element of this study, 150 
while also affording high levels of both internal and external validity (Clarkson and Hubal 2002).  151 
Furthermore, the measures of oxidative stress most commonly used in this area (e.g. 152 
thiobarbituric acid adducts/malondialdehyde) are not specific to oxidative processes (Halliwell 153 
and Chirico 1993), whereas urinary F2-isoprostanes are more reliable biomarkers of lipid 154 
peroxidation in vivo (Liu et al. 2009; Powers et al. 2010) and so were used in the present study.  155 
For completeness and to facilitate comparisons with existing research on this topic, indirect 156 
markers of skeletal muscle damage and inflammation were also determined in venous blood 157 
samples collected over the hours and days following exercise-induced muscle damage. 158 
 159 
Participants 160 
Thirty-eight healthy young men volunteered to take part in this study and their 161 
characteristics were as follows: age 22  1 yr, body mass (BM) 77.0  8.9 kg (beam balance 162 
scales, Avery Ltd), height 1.78  0.06 m (Stadiometer, Holtain Ltd), Body Mass Index 24  2 163 
kg·m
-2
, Σ triceps, biceps, subscapular and suprailiac skin-folds 34  9 mm (callipers, Salter; 164 
ACSM 1995) and max2OV
  55  5 mL∙kg-1∙min-1 (means  SD).  All participants were non-165 
smokers and habitually active in a variety of sports but were unfamiliar with the specific exercise 166 
protocol involved in this investigation.  Once fully briefed regarding the nature of the study both 167 
verbally and in writing, each participant provided written informed consent in keeping with the 168 
requirements of the Loughborough University Ethical Advisory Committee who approved this 169 
study. 170 
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Experimental Design 171 
This experiment adopted an independent-measures 2-group design whereby each 172 
participant was randomly allocated in a double-blind manner either to a group receiving placebo 173 
supplements (n=18) or a group receiving mixed antioxidant vitamin C & E supplements (n=20).  174 
Over a period of 6 weeks, these supplements were ingested as part of participants‟ habitual diets 175 
(assessed via 5-day food records and dietary analysis software: COMP-EAT 4.0, Nutrition 176 
Systems), which did not differ between groups (Placebo: 13381  3940 kJd-1, 54  7% 177 
carbohydrate, 30  6% fat, 16  4% protein, vitamin C 123  79 mg·d-1, vitamin E 7.7  2.9 178 
mg·d
-1
 versus Antioxidant: 13415  2935 kJd-1, 53  5% carbohydrate, 31  6% fat, 16  3% 179 
protein, vitamin C 120  30 mg·d-1, vitamin E 8.7  4.6 mg·d-1; mean  SD).  This 180 
supplementation regimen was continued for two days after an exercise protocol that required 181 
participants to perform approximately 90 min of intermittent high-intensity shuttle-running (a 182 
schematic of the study timeline is available via the EJAP online as Electronic Supplementary 183 
Material). 184 
 185 
Preliminary Measurements and Familiarisation 186 
The exercise intensities employed during the study were calculated relative to each 187 
participant‟s maximal oxygen uptake, determined prior to supplementation using a progressive 188 
shuttle-running protocol to exhaustion as previously described (Nicholas et al. 2000).  During the 189 
first month of supplementation participants made repeated (≥3) visits to the laboratory until they 190 
were fully familiar with the CYBEX NORM
TM 
isokinetic dynamometer (model 770), thus 191 
establishing sufficiently reliable baseline measurements of peak isometric torque in knee flexors 192 
(co-efficient of variation = 6  4%) and extensors (co-efficient of variation = 8  5%) of each 193 
participant‟s non-dominant limb.  For this test, participants completed a 5-min warm-up using a 194 
cycle ergometer (Monark 863e) at 100 W, before being individually fitted and secured into the 195 
dynamometer with knee movement restricted to the saggital plane and the axis of 196 
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extension/flexion through the femoral condyles.  The maximal range of motion about the knee 197 
was then ascertained, followed by a further isokinetic warm-up involving five flexions and 198 
extensions at 1.05 rad·s
-1
.  Peak isometric torque was then determined as the maximal rotational 199 
force voluntary achieved across 2 sustained efforts, each lasting 5 s and separated by a rest 200 
interval of 60 s.  These measurements were made while the participant was in an upright seated 201 
position (hip angle 105º relative to full extension) at knee angles of 60º and 20º relative to full 202 
extension for assessment of the knee extensors and flexors, respectively, because these joint 203 
angles are optimal for peak isometric torque production in each muscle group (Ng et al. 1994; 204 
Onishi et al. 2002).  Venous blood and urine samples were also obtained at baseline prior to 205 
supplementation. 206 
 207 
Experimental Protocol 208 
 On the fortieth day of supplementation, participants arrived in the laboratory in the 209 
morning following a 10 h overnight fast and having refrained from strenuous physical activity 210 
for at least 48 h.  Participants provided pre-exercise ratings of their perceived degree of muscle 211 
soreness using a 1-10 scale with anchor terms ranging from 1 being “Not Sore” to 10 being 212 
“Very Very Sore”, as has been employed in our previous study (Thompson et al. 2001; this scale 213 
is available via the EJAP online as Electronic Supplementary Material).  An 8 mL resting blood 214 
sample was then obtained via venepuncture from an antecubital vein and a pre-exercise urine 215 
sample was also collected.  A pre-exercise assessment of muscle function was then carried out 216 
exactly as described in relation to „Preliminary Measurements and Familiarisation‟.  Participants 217 
then drank a volume of plain water (5 mL∙kg BM-1) before the exercise protocol was initiated.  218 
The exercise protocol involved ~90 min of intermittent shuttle-running at intensities relative to 219 
each participant‟s max2OV
  (Loughborough Intermittent Shuttle Test; Nicholas et al. 2000).  The 220 
90 min was divided equally into 6 blocks each separated by a 3 min rest period during which 221 
further volumes (2 mL∙kg BM-1) of plain water were ingested.  Heart-rate (Sports Tester PE3000, 222 
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Polar, Finland) and ratings of perceived exertion (Borg 1973) were measured at regular intervals 223 
during exercise.  Ambient temperature and humidity were closely matched between treatments 224 
(Placebo: 16  1ºC, 54  6% versus Antioxidant: 16  1ºC, 55  6%).  225 
 226 
Immediately after exercise, a venous blood sample was drawn by venepuncture followed 227 
by an assessment of muscle function.  Thereafter, participants rested in the laboratory for 1 h 228 
before a further follow-up blood sample was obtained by venepuncture.  Supplements ingested 229 
on test days were taken only after this final blood sample had been consumed, coincident with 230 
the participants‟ next meal.  Approximately ( 2 h) 24 and 48 h following the cessation of 231 
exercise, participants returned to the laboratory to provide venous blood and urine samples, 232 
along with measures of muscle function.  Ratings of perceived muscle soreness were again 233 
obtained from participants at these time points and at 12 h intervals in between visits.  A sub-234 
population of the total cohort (n = 11) also provided additional follow-up measurements of 235 
muscle function after 96 and 168 h of recovery. 236 
 237 
Supplementation 238 
The antioxidant and placebo supplements were randomly assigned in a double-blind 239 
manner in the form of identical capsules, ingested twice daily with water following meals.  Each 240 
antioxidant capsule provided 400 mg vitamin C (ascorbic acid), 268 mg vitamin E (RRR--241 
tocopherol), 2 mg vitamin B6 (pyridoxine hydrochloride), 200 μg vitamin B9 (folic acid), 5 μg 242 
zinc sulphate monohydrate and 1 μg Vitamin B12 (cyanocobalamin), while placebo capsules 243 
contained only lactose (RP Scherer Limited, UK).  When considered within the context of 244 
participants‟ habitual diets, antioxidant supplementation therefore resulted in approximately an 245 
8-fold increase in daily vitamin C intake and approximately a 160-fold increase in daily vitamin 246 
E intake.  This therefore represents >1000% and ~3600% of the recommended daily allowance 247 
for vitamin C and E, respectively, but well within the upper limit that poses risk of serious 248 
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adverse effects for almost all individuals in the general population (Hathcock et al. 2005).  This 249 
dose was chosen as it is reflective of that found in commercially available supplements and is 250 
also typical of that used in previous studies where effects on oxidative stress and inflammation 251 
have been detected (Bloomer et al. 2006; Fischer et al. 2004; Goldfarb et al. 2005; Machefer et 252 
al. 2007; Mastaloudis et al. 2004; Schroder et al. 2000). 253 
 254 
Sampling and Analyses 255 
From each 8 mL blood sample, 4 mL was dispensed into a non-anticoagulant tube where 256 
it was left to clot for 45 min at room temperature and then centrifuged at 4000 g for 15 min at 4 257 
ºC.  The serum fraction was then stored at -80 ºC pending analyses at 37ºC using commercially 258 
available enzymatic colorimetric assays for myoglobin, creatine kinase and uric acid (Randox, 259 
UK) and an automated spectrophotometric analyser (COBAS-Mira plus, Roche) and for cortisol 260 
via radioimmunoassay (Coat-A-Count, Diagnostic Products Corporation, UK) and an automated 261 
gamma counter (Cobra II, Packard Instruments Company Inc, US).  Where sufficient serum was 262 
available for each participant, concentrations of interleukin-6 (R&D Systems Inc. UK), 263 
interleukin-1 receptor antagonist (R&D Systems Inc. UK), C-reactive protein (DSL, UK), heat 264 
shock protein (HSP)70 (Stressgen Biotechnologies Inc. USA) and tumor necrosis factor (TNF)-α 265 
(R&D Systems Inc. UK) were determined using commercially available Enzyme-Linked 266 
ImmunoSorbent Assays (ELISA) with a spectrophotometric plate reader (Dynex Technologies 267 
Inc. USA).  The remaining 4 mL of whole-blood was transferred into a tube containing the 268 
anticoagulant ethylenediaminetetraacetic acid (EDTA), from which triplicate 50 μl and 20 μl 269 
samples were taken for the respective manual determination of haematocrit (Hct Centrifuge and 270 
micro-haematocrit reader, Hawksley, UK) and haemoglobin via a standard 271 
cyanomethaemoglobin method using a spectrophotometer (Shimadzu 1240, Japan) applied to 272 
samples mixed with 5 ml Drabkin‟s reagent (GmbH Diagnostica, Boehringer Mannheim, 273 
Germany). From these data, changes in plasma volume were determined using the equations 274 
described by Dill & Costill (Dill and Costill 1974).  The remaining EDTA-treated whole-blood 275 
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was then also centrifuged at 4000 g for 15 min at 4 ºC and before storage at -80 ºC pending later 276 
analysis for vitamin C (after 1:1 dilution in 10% metaphosphoric acid; Sigma, UK) and vitamin 277 
E using high-performance liquid chromatography (HPLC).   278 
 279 
Plasma vitamin C concentrations were determined as in our previous studies (e.g. 280 
Thompson et al. 2004), which involed separation using a 5 μm, 250 mm x 4.6 mm c18 Luna 281 
column (Phenomenex, UK) with flow rate set at 1.2 ml·min
-1
 (producing a retention time of ~3.4 282 
min) and using a degassed mobile phase of perchloric acid (Fischer Scientific, UK) adjusted to 283 
pH 1.2 at room temperature; for analysis, plasma supernatants were diluted (1:1) in chilled 5% 284 
metaphosphoric acid (Sigma, UK) and 50 μl used for injection via an autosaampler (Basic 285 
Marathon, Spark, Netherlands).  Spectrophotometric detection was then set at a wavelength of 286 
241 nm (Pye, Unicam Ltd., UK) using a standard curve generated from ascorbic acid in the range 287 
0-300 μmol·l-1.  Similarly, plasma vitamin E (α-tocopherol) concentrations were determined 288 
according to the methods described by Hess et al. (Hess et al. 1991).  This involved separation 289 
using a 5 μm, 250 mm x 4.6 mm Beckman Ultrasphere ODS column (Beckman, High Wycombe, 290 
UK) set at 28ºC with flow rate set at 1.5 ml·min
-1
 (producing a retention time of ~7.2 min).  The 291 
mobile phase was acetonitrile:tetrahydrofurane:methanol:BHT-ammonium acetate 292 
(684:220:68:28).  Prior to analysis, vitamin E was extracted using hexane (containing 500 mg 293 
BHT·
L-
1) and rapidly dried.  The dry sample was dissolved in 200 μl of 1,4 294 
dioxan:ethanol:acetonitrile (20:20:40 by volume) and shaken for 5-10 min before injection.  295 
Detection was by fluorescence using excitation/emission of 298/328 nm (Waters 470 scanning 296 
fluorescence detector, Water, Watford, UK) using a standard curve generated from α-tocopherol 297 
in the range 0-100 μmol·l-1  298 
 299 
Lastly, the concentration of 8-isoprostane F2α (F2-isoprostanes) in urine samples was 300 
determined via commercially available monoclonal antibody-based competitive Dissociation 301 
Enhanced Lanthanide Fluoro Immuno Assay (AutoDELFIA 1235 Automatic immunoassay 302 
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system Perkin Elmer Life & Analytical Sciences, UK).  In brief, this involved all urine samples 303 
being vortexed and then allowed to stand to remove precipitates, before samples were added to 304 
an anti-mouse plate pre-washed with a dissociation enhanced lanthanide fluorescence 305 
immunoassay.  Both an anti- F2-isoprostane monoclonal antibody and a tracer (8-iso-PGF2-306 
ovalbumin-europium chelate) were then diluted in assay buffer for analysis. 307 
 308 
Statistical Analyses 309 
A two-way mixed-model analysis of variance (TreatmentxTime) was used to explore 310 
differences in the response of each group, with repeated-measures effects adjusted using the 311 
Greenhouse-Geisser correction for epsilon <0.75 and the Huynh-Feldt correction adopted for less 312 
severe asphericity.  Where significant F values were identified for either Time or 313 
TreatmentxTime, the Holm-Bonferroni step-wise correction was applied to locate variance at 314 
each time-point relative to baseline and between treatments using paired and independent t-tests, 315 
respectively (Atkinson 2002).  In addition, simple summary statistics were calculated in relation 316 
to the change from baseline to peak response, thus informing interesting questions related to the 317 
total magnitude of effect with each treatment (Hopkins et al. 2009; Matthews et al. 1990).  318 
Sample size estimations were based upon our previous investigation in which vitamin C 319 
supplementation resulted in a significantly improved recovery of peak isometric torque in the 320 
knee flexors relative to a placebo (Effect Size ~1.3; Thompson et al. 2001).  We therefore 321 
estimated that a total sample size of ~40 would be required to provide ~90% power of detecting 322 
such an effect at an alpha level of P ≤ 0.05 using the above statistical analyses. All data are 323 
expressed as mean  standard deviation. 324 
RESULTS 325 
Antioxidants 326 
 Plasma vitamin C concentrations were higher following combined vitamin C & E 327 
supplementation, both relative to pre-supplemented levels (Time: F = 131, P < 0.001) and in 328 
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relation to the change observed over time in the placebo group (Interaction: F = 17, P < 0.001).  329 
Notably, there were significant differences between treatment groups at every time-point from 330 
pre-exercise to the final sample of recovery (Figure 1; P ≤ 0.003).  Unlike vitamin C, plasma 331 
vitamin E is more resistant to acute changes with exercise and so was not measured throughout 332 
trials.  However, the response of vitamin E pre-post supplementation did differ between 333 
treatments (Interaction: F = 10, P = 0.003) such that pre-exercise concentrations were 334 
significantly higher in the group supplemented with vitamin C & E than the placebo group (11.3 335 
 3.2 versus 8.0  4.6 μmol·l-1; P = 0.02).  Serum uric acid concentrations gradually increased 336 
during exercise and then decreased during recovery (Time: F = 10, P < 0.001), with no 337 
differences in this response between treatment groups at any time-point (data not shown). 338 
 339 
 340 
Oxidative/Metabolic Stress  341 
 There were similar concentrations of F2-isoprostanes in urine samples of both groups 342 
during supplementation and over the first 24 h of post-exercise recovery (Figure 2).  However, 343 
there were differences in the decline in concentrations thereafter (Interaction: F = 0.9, P = 0.04).  344 
The overall change score from baseline to post-exercise nadir values therefore also approached 345 
significance (P = 0.08), although the tendency for slightly higher concentrations in the placebo 346 
group at baseline precluded establishment of any significant differences at the final recovery 347 
time-point per se.  Likewise, serum cortisol responses also exhibited a different time-course for 348 
each treatment (Figure 3; Interaction: F = 3.1, P = 0.05), again with no statistical differences 349 
between treatments at any time-point but a significant effect of treatment in relation to the 350 
change from pre-exercise to peak values (P = 0.02). 351 
 352 
Indices of Inflammation 353 
 The serum concentration of interleukin-6 increased dramatically in response to exercise 354 
following both treatments (Time: F = 16, P < 0.001).  Although there was no significant 355 
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interaction between treatment and time (Interaction: F = 1.6, P = 0.3), a trend was apparent for 356 
higher interleukin-6 concentrations after 1 h of recovery in the group supplemented with vitamin 357 
C & E than the placebo group (Table 1; P = 0.05).  All other inflammatory markers are 358 
summarised alongside interleukin-6 in Table 1; there were no differences between treatments. 359 
 360 
Indices of Muscle Damage 361 
 Exercise markedly increased serum myoglobin concentration (Time: F = 35, P < 0.001) 362 
and creatine kinase activity (Time: F = 23, P < 0.001), with peak values occurring after 1h and 363 
24 h of recovery, respectively (Figure 4 a/b).  These responses were very similar in both time-364 
course and magnitude between treatments, with values remaining significantly elevated relative 365 
to baseline at every follow-up time-point (P ≤ 0.05). 366 
 367 
Muscle Function 368 
 Measures of peak isometric torque for both the knee flexors (Time: F = 37, P < 0.001) 369 
and extensors (Time: F = 16, P < 0.001), along with the range of motion about this joint (Time: F 370 
= 57, P < 0.001), were significantly reduced following exercise and remained below baseline 371 
values under both treatments for at least 168 h (Table 2; P ≤ 0.01).  This pattern of responses did 372 
not differ between treatment groups. 373 
 374 
Muscle Soreness 375 
 Participants‟ subjective ratings of perceived muscle soreness were not different between 376 
treatment groups at any of the follow-up measurement time-points.  The overall pattern across 377 
both treatment groups was for pre-exercise ratings of 2  1 to reach peak soreness ratings of 5  378 
2 after 24 h of recovery (Time: F = 29, P < 0.001), which remained at this same level at both 379 
subsequent follow-up measurements (i.e. 36 and 48 h post-exercise). 380 
 381 
 17 
Additional Information 382 
 Estimated changes in plasma volume were very similar between treatment groups in 383 
response to supplementation, exercise and during recovery (Interaction: F = 0.3, P = 0.9).  There 384 
was a progressive increase in plasma volume over time relative to pre-supplemented values 385 
across both groups (Time: F = 6.7, P < 0.001), with the percentage change significantly above 386 
baseline after 24 h (5.5  2.5%; P = 0.01) and 48 h (7.9  11.5%; P = 0.001) of recovery.  387 
Averaged across all measurements made during the exercise protocol, mean heart rate was 166  388 
14 beats·min
-1
 and the mean rating of perceived exertion (6-20 scale) was 14  2, with both 389 
variables well matched between treatment groups. 390 
391 
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DISCUSSION 392 
This study was designed to examine whether supplementation with mixed antioxidant 393 
(primarily vitamin C & E) supplements can reduce oxidative stress and facilitate recovery 394 
following exercise-induced muscle damage.  Our original hypothesis was based upon the 395 
rationale that individual antioxidants such as vitamin C and E have been found to reduce 396 
oxidative stress, inflammation and/or have improved recovery of muscle function (Alessio et al. 397 
1997; Cannon et al. 1991; Jakeman and Maxwell 1993; Meydani et al. 1993; Thompson et al. 398 
2001).  Therefore, it was reasonable to suggest that a mixed antioxidant supplement would not 399 
only combine such benefits but also facilitate interaction between different antioxidant 400 
mechanisms to attain a synergistic benefit.  For example, while oxidation of the chromanol 401 
region of α-tocopherol can certainly delay oxidative membrane damage, this process itself 402 
transforms vitamin E into a free radical (tocopherolxyl) (Dekkers et al. 1996).  This is of 403 
relevance as, in addition directly quenching free radicals, a related role of vitamin C may be to 404 
regenerate vitamin E back to its antioxidant form (tocopherol; Goldfarb 1993).  However, 405 
notwithstanding the above rationale and contrary to our hypothesis, the present results suggest 406 
that there are no beneficial effects to be gained from supplementation with vitamin C & E in 407 
combination.  Specifically, although exercise resulted in a marked increase in protein/enzyme 408 
leakage from skeletal muscle, initiation of inflammatory responses and impairment of muscle 409 
function, prior supplementation with these particular antioxidant vitamins did not attenuate any 410 
of these effects relative to placebo supplements. 411 
 412 
 Recovery of muscle function was employed as the primary outcome measure in this study 413 
given both the clear practical interpretation of resultant data and the relatively valid reflection of 414 
muscle damage provided (Clarkson and Hubal 2002).  This is the first time that the efficacy of 415 
combined vitamin C & E supplementation has been assessed using this outcome measure in 416 
relation to exercise representative of that most commonly performed by athletes or habitual 417 
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exercisers.  Nonetheless, the absence of any benefit associated with vitamin C & E 418 
supplementation reported in the present study is consistent with two other studies that have 419 
measured muscle function in recovery from either muscle-specific resistance exercise (Bloomer 420 
et al. 2007) or ultra-endurance exercise (Mastaloudis et al. 2006) to evaluate similar doses of 421 
combined vitamin C & E supplements.  While it therefore remains a distinct possibility that these 422 
findings may be specific to the precise antioxidant mixtures provided in these studies, it is 423 
arguably less likely that alternative forms of exercise would reveal a positive effect of these 424 
particular antioxidants supplements because they have now been shown to be equally ineffective 425 
across all three exercise modes involving high load (i.e. resistance), high repetition (i.e. 426 
endurance) and high frequency/rate (i.e. intermittent sprint) muscle actions. 427 
 428 
 The increase in plasma vitamin C concentrations that occurred in response to combined 429 
vitamin C & E supplementation was elevated even further during exercise but only to a similar 430 
extent as in the placebo group.  This is in agreement with previous reports (Gleeson et al. 1987; 431 
Thompson et al. 2001) and suggests that endogenous ascorbic acid release during exercise may 432 
be independent of prior supplementation.  Moreover, while the first hour of recovery saw further 433 
increased plasma vitamin C concentrations only in the group supplemented with this vitamin, 434 
subsequent measurements after 24 and 48 h of recovery revealed a progressive return to below 435 
pre-exercise values despite continued supplementation over this period.  Interestingly, an earlier 436 
study to document a similar effect during recovery also found a strong positive correlation 437 
between the plasma responses of vitamin C and cortisol to exercise, from which it was reasoned 438 
that endogenous release of vitamin C from the adrenal glands may be directly associated with the 439 
release of cortisol (Gleeson et al. 1987).  This reasoning may therefore explain why cortisol 440 
responses were lower for the group supplemented with combined vitamin C & E in the present 441 
study and others that have supplemented with vitamin C alone (Peters et al. 2001; i.e. increased 442 
vitamin C availability in other tissues may reduce adrenal secretion of both vitamin C and 443 
cortisol). 444 
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 445 
 Apart from the effects on plasma vitamin C and E and serum cortisol, the only other 446 
outcome variables showing any differences between treatment groups were concentrations of F2-447 
isoprostanes in urine and interleukin-6 in serum.  The general pattern for greater responses of F2-448 
isoprostanes and interleukin-6 to exercise after combined vitamin C & E supplementation is 449 
inconsistent with all extant studies in this area, which have always reported oxidative stress and 450 
inflammatory markers to be either lower (Bloomer et al. 2006; Fischer et al. 2004; Goldfarb et al. 451 
2005; Machefer et al. 2007; Mastaloudis et al. 2004; Schroder et al. 2000) or unaffected 452 
(Bloomer et al. 2007; Bloomer et al. 2006; Dawson et al. 2002; Kanter et al. 1993; Mastaloudis 453 
et al. 2004; Petersen et al. 2001; Rokitzki et al. 1994; Teixeira et al. 2009).  It is therefore 454 
difficult to account for the present findings.  One possibility is that the apparent effect in relation 455 
to F2-isoprostanes may represent a type I statistical error, particularly given the large inter-456 
individual variability for this measure, which questions whether a worthwhile difference between 457 
treatment groups truly existed.  Nevertheless, what is clear is that there was certainly no 458 
reduction in the concentration of F2-isoprostanes as was hypothesised.  In contrast, the effect of 459 
vitamin C & E supplementation on interleukin-6 concentrations after 1 h of recovery was far 460 
more consistent between individuals in each group (Effect Size = 1.4) and is very similar in 461 
magnitude (~80% higher than placebo) to existing data, albeit in the opposite direction (Fischer 462 
et al. 2004; Thompson et al. 2001).  The precise reason for these divergent findings clearly 463 
requires further examination but might be explained by the fact that the supplements used in the 464 
present study provided 60-100% more vitamin C (i.e. 800 mg·d
-1
) than previously reported (i.e. 465 
400-500 mg•d-1;  Fischer et al. 2004; Thompson et al. 2001).  This is important in view of the 466 
fact that vitamin C is a redox agent and, as such, has been found to operate as a prooxidant in 467 
some circumstances (Carr and Frei 1999), with suggestions that the pharmacologic quantities of 468 
vitamin C found in supplements (as opposed to foods) may have „unbalanced biochemistry‟ that 469 
actually favours free radical production (Herbert 1994).  470 
 471 
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 One final point of note arising from this study relates to the plasma heat shock protein 472 
(HSP)70 concentrations, which were unaffected by vitamin C & E supplementation but increased 473 
from 1.2  1.0 ng·ml-1 pre-exercise to a peak of 6.6  5.7 ng·ml-1 immediately post-exercise (P = 474 
0.003) when considered across both treatments.  Importantly, systemic HSP70 may play an 475 
important signalling role between various tissues (Calderwood et al. 2007) and, to our 476 
knowledge, this is the first time that this variable has been reported in response to intermittent 477 
exercise.  By comparison, plasma HSP70 responses to a typical ironman triathlon race or even 478 
just 45-60 min of treadmill running at various intensities/gradients can be between 2-4 times 479 
higher than the values reported here (Peake et al. 2005; Suzuki et al. 2006).  To consider HSP70 480 
within the context of the exercise protocol and intervention applied in the present study, it is 481 
interesting that one of the training adaptations to 6 weeks of intermittent running four times per 482 
week is an increased muscle protein content of HSP70 (Morton et al. 2009), which can also be 483 
achieved through dietary supplementation with 500 mg·d
-1
 of vitamin C for 8 weeks (Khassaf et 484 
al. 2003). 485 
 486 
CONCLUSIONS 487 
 Within the context of the particular supplementation regimen and exercise stressors 488 
examined in the present study, there was no benefit of 6-weeks mixed antioxidant vitamin C & E 489 
supplementation in relation to recovery from exercise-induced muscle damage, although further 490 
investigations may be warranted to explore the unanticipated responses of interleukin-6 and 491 
cortisol.  While it also remains to be determined whether other distinct antioxidant mixtures may 492 
confer the hypothesised effects under related conditions, the lack of beneficial effects reported 493 
here across a comprehensive and practically relevant range of outcome measures and in a 494 
relatively large cohort may question the need for future studies designed to evaluate the efficacy 495 
of similar vitamin C & E supplements for improving recovery in terms of muscle function and 496 
soreness. 497 
498 
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Table 1:  Serum concentrations of selected inflammatory/stress markers prior to and during 
recovery from exercise after 6-wk mixed antioxidant vitamin C & E or placebo supplementation. 
 Exercise Recovery 
 Pre Post 1 h  24 h 48 h 
Interleukin-6 (pg∙ml-1) # *#  
Antioxidant (n = 9) 1.1  0.7 11.8  7.4 11.3  3.4 2.8  3.9 0.9  0.4 
Placebo (n = 9) 1.6  1.7 9.5  10.2 6.2  3.8 2.1  1.8 1.8  2.7 
 
Interleukin-1ra (pg∙ml-1) # #  
Antioxidant (n = 20) 205  109 559  561 1523  1402 270  202 224  107 
Placebo (n = 18) 204  70 435  359 1137  1055 247  86 388  655 
 
C-reactive protein (ng∙ml-1) 
Antioxidant (n = 7) 788  551 416  220 1024 1146 6431  3256 2617  1670 
Placebo (n = 11) 2739  3725 1842  2925 1223  720 4941  5023 4740  5116 
 
TNF-α (ng∙ml-1) 
Antioxidant (n = 19) 1.7  1.5 1.7  1.5 1.6  1.3 1.4  1.3 1.2  0.6 
Placebo (n = 16) 1.5  1.1 1.6  0.7 1.6  0.7 1.5  0.7 1.5  0.7 
 
HSP70 (ng∙ml-1) # #  
Antioxidant (n = 20) 1.4  1.2 6.6  5.7 5.1  4.2 1.1  0.9 0.9  0.7 
Placebo (n = 18) 1.0  0.7 6.5  5.8 4.9  4.3 1.0  0.8 0.6  0.5 
* denotes time-point different between treatments (P = 0.05) without treatmentxtime interaction. 
# denotes time-points different from baseline across both treatments (P ≤ 0.02). 
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Table 2:  Peak isometric torque of the knee extensors and flexors prior to and during recovery 
from exercise after 6-wk mixed antioxidant vitamin C & E or placebo supplementation. 
 Exercise Recovery 
 Pre Post 24 h  48 h 96 h 168 h 
Flexion (N∙m) # # # # ‡ # ‡ 
Antioxidant (n = 20) 203  43 172  43 170  49 169  41  168  43 178  40 
Placebo (n = 18) 204  47 169  41 163  43 163  46 147  21 158  35 
 
Extension (N∙m) # # # # ‡ # ‡ 
Antioxidant (n = 20) 317  69 269  59 282  66 281  65 328  71 336  66 
Placebo (n = 18) 308  54 259  46 276  57 292  57 298  57 278  73 
 
Range of Motion (º) # # # # ‡ # ‡ 
Antioxidant (n = 20) 117  8 106  8 106  10 105  11 102  5 108  4 
Placebo (n = 18) 120  7 106  6 105  7 106  10 102  6 103  3 
# denotes time-points different from baseline (P ≤ 0.01). 
‡ denotes n = 6 and n = 5 for antioxidant and placebo groups, respectively. 
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Fig. 1  Plasma vitamin C concentrations before and after 6-weeks mixed antioxidant vitamin C & 665 
E or placebo supplementation and then in recovery from exercise-induced muscle damage 666 
(Interaction: F = 17, P < 0.001).  * denotes time-points different between treatments (P ≤ 0.003); 667 
# denotes time-points different from baseline across both treatments (P ≤ 0.005). 668 
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Fig. 2  Urine F2-isoprostane concentrations before and after 6-weeks mixed antioxidant vitamin 671 
C & E or placebo supplementation and then in recovery from exercise-induced muscle damage 672 
(Interaction: F = 0.9, P = 0.04). 673 
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Fig. 3  Serum cortisol concentrations prior to and during recovery from exercise following 6-676 
weeks mixed antioxidant vitamin C & E or placebo supplementation (Interaction: F = 3.1, P = 677 
0.05).  # denotes time-points different from baseline across both treatments (P ≤ 0.03). 678 
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Fig. 4  Serum myoglobin concentrations (a) and creatine kinase activities (b) prior to and during 681 
recovery from exercise following 6-weeks mixed antioxidant vitamin C & E or placebo 682 
supplementation. # denotes time-points different from baseline across both treatments (P ≤ 0.05). 683 
